Several studies have shown that angiotensin-converting enzyme inhibitors and angiotensin
II receptor blockers are useful in the treatment of hypertension, cardiovascular disease …

Survivors of myocardial infarction (MI) are at high risk of disability and death. This is due to
infarct-related complications such as heart failure, cardiac remodeling with progressive …

Los antagonistas de los receptores AT 1 de la angiotensina II (ARA-II) son un grupo de
fármacos que antagonizan las acciones que la angiotensina II (A-II) ejerce por mediación de …

The aim of transplant assessment programmes is selecting a patient who will benefit from
receiving a cardiac transplant. The recipient should be expected to live longer with a better …

Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our
knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically …

Candesartan cilexetil is a nonpeptide selective blocker of the angiotensin II receptor sub-
type 1. It is a prodrug that is converted to its active metabolite during its variable absorption …

The Cleveland Clinic Cardiology Board Review offers thorough preparation for board
certification and recertification exams in cardiology. It is written by distinguished clinicians …

O tratamento de ICD representa um desafio até mesmo para o médico experiente. Os
avanços alcançados nas pesquisas propiciaram novas opções de tratamento que estão …

The most recent trials of ARBs in heart failure and myocardial infarction patients suggest a
role for angiotensin receptor blockers in patients with heart failure who are intolerant to ACE …